© 2003 by Oxford University Press
Journal of the National Cancer Institute Monographs, No. 31, 52-56,
2003
© 2003 Oxford University Press
ARTICLE |
Chapter 8: Human Papillomavirus and Skin Cancer
Correspondence to: Herbert Pfister, Ph.D., Institute of Virology, University of Cologne, Fürst-Pückler-Str. 56, 50935, Cologne, Germany (e-mail: herbert. pfister{at}medizin.uni-koeln.de).
A high prevalence of human papillomavirus (HPV) DNA, particularly in squamous cell skin carcinoma of immunosuppressed but also of immunocompetent patients, has renewed great interest in a possible etiologic role of HPV in nonmelanoma skin cancer. It is difficult, however, to interpret these findings against a background of low-level infections with multiple HPV types from supergroup B (HPV4-related and epidermodysplasia verruciformis [EV] HPV), probably acquired by everyone early in and throughout life. Thus far, no high-risk HPV types have been identified. Because of the low copy numbers of HPV DNA in skin cancers, probably not every tumor cell contains a viral genome, which is compatible with cutaneous HPV being possibly important for tumor initiation and progression, but not for maintenance of the malignant phenotype. The question with regard to high-risk types should, therefore, be readdressed in case–control studies on the basis of serology, which can reveal viral activities over years. The viruses lingering in all people are apparently activated by sunlight (UV) exposure, by immunosuppression, and by hyperproliferation of the epithelium (psoriasis) and/or in the specific genetic background of the host (EV). It is intriguing that most of these factors are established risk factors in skin carcinogenesis. The weak transforming activity of cutaneous HPV in vitro compared with the transforming activity of genital HPV may explain the need for activators and synergistic factors. The antiapoptotic activities of E6 proteins of cutaneous HPV could be relevant to oncogenesis in the interplay with UV exposure. Prospective studies should determine the kinetics of HPV activation relative to tumor development.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. N. C. de Koning, S. J. Weissenborn, D. Abeni, J. N. Bouwes Bavinck, S. Euvrard, A. C. Green, C. A. Harwood, L. Naldi, R. Neale, I. Nindl, et al. Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma J. Gen. Virol., July 1, 2009; 90(7): 1611 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Weissenborn, M. N. C. De Koning, U. Wieland, W. G. V. Quint, and H. J. Pfister Intrafamilial Transmission and Family-Specific Spectra of Cutaneous Betapapillomaviruses J. Virol., January 15, 2009; 83(2): 811 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Handisurya, R. Gambhira, C. Schellenbacher, S. Shafti-Keramat, O. Forslund, M. Favre, and R. Kirnbauer Serological relationship between cutaneous human papillomavirus types 5, 8 and 92 J. Gen. Virol., January 1, 2009; 90(1): 136 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Lange, K. Tobler, C. Favrot, M. Muller, J. O. Nothling, and M. Ackermann Detection of Antibodies against Epidermodysplasia Verruciformis-Associated Canine Papillomavirus 3 in Sera of Dogs from Europe and Africa by Enzyme-Linked Immunosorbent Assay Clin. Vaccine Immunol., January 1, 2009; 16(1): 66 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C.-H. Chen, N. A. J. McMillan, and A. Antonsson Human papillomavirus type spectrum in normal skin of individuals with or without a history of frequent sun exposure J. Gen. Virol., November 1, 2008; 89(11): 2891 - 2897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Dell'Oste, B. Azzimonti, M. Mondini, M. De Andrea, C. Borgogna, R. Mesturini, R. Accardi, M. Tommasino, S. Landolfo, U. Dianzani, et al. Altered expression of UVB-induced cytokines in human papillomavirus-immortalized epithelial cells J. Gen. Virol., October 1, 2008; 89(10): 2461 - 2466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Vasiljevic, K. Hazard, J. Dillner, and O. Forslund Four novel human betapapillomaviruses of species 2 preferentially found in actinic keratosis J. Gen. Virol., October 1, 2008; 89(10): 2467 - 2474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-S. Gabet, R. Accardi, A. Bellopede, S. Popp, P. Boukamp, B. S. Sylla, J. A. Londono-Vallejo, and M. Tommasino Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38 FASEB J, February 1, 2008; 22(2): 622 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Nafz, A. Kohler, M. Ohnesorge, I. Nindl, E. Stockfleth, and F. Rosl Persistence of Mastomys natalensis papillomavirus in multiple organs identifies novel targets for infection J. Gen. Virol., October 1, 2007; 88(10): 2670 - 2678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Reelfs, Y.-Z. Xu, A. Massey, P. Karran, and A. Storey Thiothymidine plus low-dose UVA kills hyperproliferative human skin cells independently of their human papilloma virus status Mol. Cancer Ther., September 1, 2007; 6(9): 2487 - 2495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Gheit, G. Billoud, M. N. C. de Koning, F. Gemignani, O. Forslund, B. S. Sylla, S. Vaccarella, S. Franceschi, S. Landi, W. G. V. Quint, et al. Development of a Sensitive and Specific Multiplex PCR Method Combined with DNA Microarray Primer Extension To Detect Betapapillomavirus Types J. Clin. Microbiol., August 1, 2007; 45(8): 2537 - 2544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Chan and J. S. Berek Impact of the Human Papilloma Vaccine on Cervical Cancer J. Clin. Oncol., July 10, 2007; 25(20): 2975 - 2982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. C. de Koning, L. Struijk, J. N. B. Bavinck, B. Kleter, J. ter Schegget, W. G. V. Quint, and M. C. W. Feltkamp Betapapillomaviruses frequently persist in the skin of healthy individuals J. Gen. Virol., May 1, 2007; 88(5): 1489 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gottschling, A. Stamatakis, I. Nindl, E. Stockfleth, A. Alonso, and I. G. Bravo Multiple Evolutionary Mechanisms Drive Papillomavirus Diversification Mol. Biol. Evol., May 1, 2007; 24(5): 1242 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-A. Mendoza, Y. Jacob, P. Cassonnet, and M. Favre Human Papillomavirus Type 5 E6 Oncoprotein Represses the Transforming Growth Factor {beta} Signaling Pathway by Binding to SMAD3 J. Virol., December 15, 2006; 80(24): 12420 - 12424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Lipke An Armamentarium of Wart Treatments Clin. Med. Res., December 1, 2006; 4(4): 273 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. de Koning, W. Quint, L. Struijk, B. Kleter, P. Wanningen, L.-J. van Doorn, S. J. Weissenborn, M. Feltkamp, and J. ter Schegget Evaluation of a Novel Highly Sensitive, Broad-Spectrum PCR-Reverse Hybridization Assay for Detection and Identification of Beta-Papillomavirus DNA. J. Clin. Microbiol., May 1, 2006; 44(5): 1792 - 1800. [Abstract] [Full Text] [PDF]
|
|